Services: What
We Do For You.
Studies
Better Resolutions for Better Solutions.
Distribution Studies
- 5Comprehensive biodistribution data
- 5Longitudinal tracking in the same subject for higher data quality
- 5Previously undetectable molecules become visible
Safety Studies
Gain precise data on deposition, metabolism, and excretion to assess accumulation in critical organs such as liver or kidneys.
- 5Detect risks earlier than ever
- 5Strengthen FDA/EMA documentation
- 5Reduce late-stage failures with reliable preclinical data
Efficacy Studies
Measure whether drugs or carriers reach and act at their intended target. Repeated in vivo measurements in the same subject provide robust PK/PD insights.
- 5Gain direct evidence of therapeutic efficacy
- 5Longitudinal data reduces variability and animal use
- 5Faster go/no-go decisions with clearer efficacy insights
Services
Our Applications For You
In vivo small animal application (Status: Offering)
Customized tracking of drugs or labeled cells in living animals, with repeated time-series measurements at safe radiation doses. Already approved in a Crohn’s Disease mouse model.
- 5Non-invasive with high sensitivity and resolution
- 5Arbitrary tissue depth unlike optical methods
- 5Several time points in the same animal, minimizing animal use
Ex vivo (in situ) application (Status: Offering)
Tracking of molecules in biological samples and artificial tissues for pharma and cosmetics R&D.
- 5Non-invasive (samples undamaged)
- 5Arbitrary tissue depth unlike laser ablation
- 5Higher spatial resolution than ICP-MS
In vitro application (Status: Offering)
Analytics of nanoparticle or drug uptake into cultured cells (e.g. antibody-functionalized nanoparticles in tumor cells).
- 5Non-invasive
- 5Arbitrary tissue depth
- 5High spatial resolution compared to ICP-MS
Assay screening application (Status: Offering)
High-throughput measurement of drug or ligand uptake using a fraction of the cells required for ICP-MS.
- 5High throughput (≈1 min per vial)
- 5Very low cell number required (~100 vs. ~500,000 for ICP-MS)
- 5Detection down to 0.2 pg per cell
Feasibility & design studies (Status: Offering)
Simulations that predict expected sensitivity and help design the optimal experimental setup.
- 5Fast feasibility check before costly in vivo research
- 5Optimized tracking parameters
- 5Upfront confidence in study design
In vivo human application (Status: R&D phase)
Future extension of XFI into human studies, enabling direct in vivo tracking of drugs and cells in patients. R&D is ongoing.
How We Work Together
Step 1 | Initial Meeting
We listen closely to understand your objectives and define the parameters needed for an optimal study proposal.
